REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,087,270 | -19.4% | 256,043 | -22.1% | 0.00% | -25.0% |
| Q2 2023 | $8,791,067 | +7.8% | 328,638 | -12.7% | 0.00% | +33.3% |
| Q1 2023 | $8,153,907 | +58.2% | 376,450 | +74.0% | 0.00% | +50.0% |
| Q4 2022 | $5,154,648 | +2.8% | 216,400 | -14.9% | 0.00% | 0.0% |
| Q3 2022 | $5,014,000 | +30.4% | 254,262 | +28.9% | 0.00% | 0.0% |
| Q2 2022 | $3,845,000 | -33.2% | 197,297 | -12.6% | 0.00% | 0.0% |
| Q1 2022 | $5,757,000 | +116.7% | 225,668 | +113.7% | 0.00% | +100.0% |
| Q4 2021 | $2,657,000 | +12.2% | 105,582 | +22.6% | 0.00% | 0.0% |
| Q3 2021 | $2,369,000 | +12.9% | 86,100 | +30.3% | 0.00% | 0.0% |
| Q2 2021 | $2,098,000 | -20.0% | 66,100 | +15.6% | 0.00% | 0.0% |
| Q1 2021 | $2,624,000 | +17.7% | 57,200 | +1.6% | 0.00% | 0.0% |
| Q4 2020 | $2,229,000 | +14.6% | 56,300 | +0.7% | 0.00% | 0.0% |
| Q3 2020 | $1,945,000 | +178.3% | 55,900 | +152.6% | 0.00% | – |
| Q2 2020 | $699,000 | – | 22,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |